Displaying drugs 10851 - 10875 of 12697 in total
Seletalisib
Seletalisib has been used in trials studying the treatment and basic science of Primary Sjogren's Syndrome.
Investigational
Matched Description: … Seletalisib has been used in trials studying the treatment and basic science of Primary Sjogren's Syndrome …
Crolibulin
Crolibulin has been used in trials studying the treatment of Solid Tumor and Anaplastic Thyroid Cancer.
Investigational
Matched Description: … Crolibulin has been used in trials studying the treatment of Solid Tumor and Anaplastic Thyroid Cancer …
AG-24322
AG-024322 has been used in trials studying the treatment of Neoplasms and Lymphoma, Non-Hodgkin.
Investigational
Matched Description: … AG-024322 has been used in trials studying the treatment of Neoplasms and Lymphoma, Non-Hodgkin. …
GDC-0349
GDC-0349 has been used in trials studying the treatment of Non-Hodgkin's Lymphoma, Solid Tumor.
Investigational
Matched Description: … GDC-0349 has been used in trials studying the treatment of Non-Hodgkin's Lymphoma, Solid Tumor. …
Apararenone
Apararenone is under investigation in clinical trial NCT02531568 (Drug Interaction Study of Warfarin and MT-3995).
Investigational
Matched Description: … Apararenone is under investigation in clinical trial NCT02531568 (Drug Interaction Study of Warfarin …
LB-P8
LB-P8 is an investigational live biotherapeutic product consisting of a single bacterial strain (Leuconostoc citreum).
Investigational
Matched Description: … LB-P8 is an investigational live biotherapeutic product consisting of a single bacterial strain (_Leuconostoc …
Izuralimab
Izuralimab is under investigation in clinical trial NCT05879185 (A Study of Xmab23104 in People With Sarcoma).
Investigational
Matched Description: … Izuralimab is under investigation in clinical trial NCT05879185 (A Study of Xmab23104 in People With …
Leflutrozole
Leflutrozole is under investigation in clinical trial NCT02908074 (A 6 Month Safety Extension Study of MBGS205).
Investigational
Matched Description: … Leflutrozole is under investigation in clinical trial NCT02908074 (A 6 Month Safety Extension Study of …
alpha-D-quinovopyranose
The pyranose form of D-quinovose with an α-configuration at the anomeric position .
Experimental
Matched Description: … The pyranose form of D-quinovose with an α-configuration at the anomeric position . …
Atl146e
ATL146e is an anti-inflammatory compounds which is an agonist of A2A adenosine receptors.
Investigational
Matched Description: … ATL146e is an anti-inflammatory compounds which is an agonist of A2A adenosine receptors. …
FAV-201
FAV-201 is a patient-specific immunotherapy for the treatment of T-cell lymphoma.
Investigational
Matched Description: … FAV-201 is a patient-specific immunotherapy for the treatment of T-cell lymphoma. …
Bryostatin 1
Bryostatin 1 has been investigated for the treatment of HIV Infection and Alzheimer's Disease.
Investigational
Matched Description: … Bryostatin 1 has been investigated for the treatment of HIV Infection and Alzheimer's Disease. …
Interleukin-7
Interleukin 7 has been used in trials studying the treatment of Metastatic Breast Cancer.
Investigational
Matched Description: … Interleukin 7 has been used in trials studying the treatment of Metastatic Breast Cancer. …
Esreboxetine
Esreboxetine has been used in trials studying the treatment and basic science of Fibromyalgia.
Investigational
Matched Description: … Esreboxetine has been used in trials studying the treatment and basic science of Fibromyalgia. …
Muscimol
Muscimol has been used in trials studying the treatment of Epilepsy and Parkinson's Disease.
Investigational
Matched Description: … Muscimol has been used in trials studying the treatment of Epilepsy and Parkinson's Disease. …
AKN-028
AKN-028 has been used in trials studying the treatment of Acute Myeloid Leukemia.
Investigational
Matched Description: … AKN-028 has been used in trials studying the treatment of Acute Myeloid Leukemia. …
Methylinositol
Methylinositol has been used in trials studying the treatment of Dementia and Alzheimer's Disease.
Investigational
Matched Description: … Methylinositol has been used in trials studying the treatment of Dementia and Alzheimer's Disease. …
Nattokinase
Nattokinase is under investigation in clinical trial NCT00749801 (Efficacy and Safety of Geneferm Nattokinase).
Investigational
Matched Description: … Nattokinase is under investigation in clinical trial NCT00749801 (Efficacy and Safety of Geneferm Nattokinase …
Idursulfase beta
Idursulfase beta is under investigation in clinical trial NCT01645189 (Safety and Efficacy of Hunterase).
Investigational
Matched Description: … Idursulfase beta is under investigation in clinical trial NCT01645189 (Safety and Efficacy of Hunterase …
CDX-6210
CDX-6210 is a modified version of a leucine decarboxylase enzyme from Planctomycetaceae bacterium.
Investigational
Matched Description: … CDX-6210 is a modified version of a leucine decarboxylase enzyme from _Planctomycetaceae bacterium_. …
PT886
PT886 is a bispecific antibody against Claudin 18.2 and cluster of differentiation 47 (CD47)
Investigational
Matched Description: … PT886 is a bispecific antibody against Claudin 18.2 and cluster of differentiation 47 (CD47) …
MLN0415
MLN0415 is a novel, small molecule IKK2 inhibitor, discovered by Millennium scientists. In preclinical studies, MLN0415 was shown to decrease NF-kB activation and down-regulate the expression of a number of inflammatory proteins. Because inflammatory proteins play a critical role in inflammation and drive the inflammatory response to disease, controlling these...
Investigational
Matched Description: … a number of inflammatory proteins. ... preclinical studies, MLN0415 was shown to decrease NF-kB activation and down-regulate the expression of …
Alferminogene tadenovec
Alferminogene tadenovec, Cardium’s lead product candidate, is being developed for the potential treatment of myocardial ischemia that gives rise to angina symptoms associated with coronary heart disease. Alferminogene tadenovec represents a new therapeutic class of biologics designed to promote angiogenesis and thereby improve blood flow following a one-time intracoronary administration...
Investigational
Matched Description: … Alferminogene tadenovec, Cardium’s lead product candidate, is being developed for the potential treatment of ... Alferminogene tadenovec represents a new therapeutic class of biologics designed to promote angiogenesis …
Col-118
COL-118, a topical compound based on the SansRosa technology, for the treatment of redness associated with rosacea and other skin disorders. It is a believed to reduce erythema by constricting enlarged blood vessels in facial tissue. Col-118 is a unique formulation and presentation of Brimonidine, which is a selective alpha-2...
Investigational
Matched Description: … COL-118, a topical compound based on the SansRosa technology, for the treatment of redness associated ... Col-118 is a unique formulation and presentation of Brimonidine, which is a selective alpha-2 adrenergic …
GnRH pharmaccine
The GnRH pharmaccine consists of synthetic peptides (constructed to "look like" GnRH), which are bound chemically to a carrier and suspended in a proprietary "delivery vehicle". The pharmaccine is administered intramuscularly to the patient by injection and induces an immune response or production of antibodies in the patient, which neutralize...
Investigational
Matched Description: … The GnRH pharmaccine consists of synthetic peptides (constructed to "look like" GnRH), which are bound ... administered intramuscularly to the patient by injection and induces an immune response or production of …
Displaying drugs 10851 - 10875 of 12697 in total